NCT06904378 2026-05-19ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal AdenocarcinomaWashington University School of MedicinePhase 1/2 Recruiting61 enrolled